REPLIGEN CORP — Director's Dealing 2020

Aug 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-08-06

Reporting Person: KURIYEL RALF (Senior VP, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-06	Common Stock	M	5000	$33.87	Acquired	31089	Direct
2020-08-06	Common Stock	S	5000	$153.79	Disposed	26089	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-06	Stock Option (Right to Buy)	$33.87	M	5000	Disposed	2028-03-01	Common Stock (5000)	Direct

Footnotes

F1: $153.79 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.53 to $154.05, inclusive. The reporting person undertakes to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: 6,566 of the shares underlying this option have vested. 4,284 shares shall vest and become exercisable on March 1, 2021.